Axios @axios
The VA has excluded Aduhelm, the Alzheimer's drug made by Biogen and Eisai, from its list of approved drugs due to the drug's "lack of evidence of a robust and meaningful clinical benefit and the known safety signal." https://t.co/NEDb0MoKmj — PolitiTweet.org